Halpern, A. B., Othus, M., Huebner, E. M., Scott, B. L., Hendrie, P. C., Percival, M.-E. M., Becker, P. S., Smith, H. A., Oehler, V. G., Orozco, J. J., Cassaday, R. D., Gardner, K. M., Chen, T. L., Buckley, S. A., Orlowski, K. F., Anwar, A., Estey, E. H. and Walter, R. B. (2019) “Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms”, Haematologica. Pavia, Italy, 104(4), pp. e143-e146. doi: 10.3324/haematol.2018.204792.